CV-6209: A Potent Platelet Activating Factor Receptor Antagonist for Advanced Research

Discover the superior capabilities of CV-6209, a highly selective antagonist for Platelet Activating Factor (PAF) receptors. Ideal for discerning researchers and procurement specialists seeking high-purity pharmacological tools. We are a trusted supplier in China, ensuring consistent availability and competitive pricing for your critical research needs.

Get a Quote & Sample

Key Advantages of Sourcing CV-6209 from NINGBO INNO PHARMCHEM

Exceptional Purity for Accurate Research

Our CV-6209 meets stringent purity standards (≥97.0%), ensuring that your experimental results are accurate and reproducible. Trust NINGBO INNO PHARMCHEM as your dedicated supplier for research-grade chemicals.

Competitive Pricing & Bulk Availability

As a leading chemical manufacturer in China, we provide CV-6209 at competitive prices, making advanced research more accessible. We cater to both small-scale research needs and larger procurement demands.

Expert Support & Customization

Leverage our expertise in chemical synthesis and supply chain management. We offer dedicated support to help you buy CV-6209 and other specialized research chemicals with confidence.

Applications of CV-6209 in Biomedical Research

Cardiovascular Research

Investigate the role of Platelet Activating Factor in cardiovascular diseases, hypertension, and thrombotic events. Purchase CV-6209 to explore therapeutic targets.

Inflammation Studies

Understand the inflammatory cascade mediated by PAF. CV-6209 is a critical tool for researchers studying inflammatory responses and developing anti-inflammatory strategies.

Platelet Function Analysis

Precisely study human platelet aggregation and the mechanisms of anticoagulation. Buy CV-6209 for reliable in vitro and in vivo platelet function assays.

Pharmacological Tool Development

Utilize CV-6209 as a benchmark antagonist in the discovery and development of novel PAF-related therapeutics. Consult with our team for bulk purchase options.